| 2020 |
Pignolo RJ, Cheung K, Kile S, Fitzpatrick MA, De Cunto C, Al Mukaddam M, Hsiao EC, Baujat G, Delai P, Eekhoff EMW, Di Rocco M, Grunwald Z, Haga N, Keen R, Levi B, Morhart R, Scott C, Sherman A, Zhang K, Kaplan FS. Self-reported baseline phenotypes from the international fibrodysplasia ossificans progressiva (fop) association global registry. Bone. May 2020;134:115274. |
3 |
0 |
| 2021 |
Kaplan FS, Teachey DT, Andolina JR, Siegel DM, Mancilla EE, Hsiao EC, Al Mukaddam M, Rocke DM, Pignolo RJ. Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva. Bone. September 2021;150:116016. |
0 |
0 |
| 2022 |
Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, Ton AN, Sharma A, Hellman J, Tomoda K, Nakamura MC, Hsiao EC. Corrigendum to “ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages” [Bone. 153 2021 Dec; 116129. doi:10.1016/j.bone.2021.116129. Epub 2021 jul 24. PMID: 34311122]. Bone. May 2022;158:116325. |
0 |
0 |
| 2022 |
Pignolo RJ, Baujat G, Hsiao EC, Keen R, Wilson A, Packman J, Strahs AL, Grogan DR, Kaplan FS. Palovarotene for fibrodysplasia ossificans progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial. J Bone Miner Res. October 2022;37(10):1891-1902. |
1 |
0 |
| 2022 |
Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor KE, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC. Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1R206H-specific human cellular and zebrafish models. J Bone Miner Res. November 2022;37(11):2058-2076. |
1 |
1 |
| 2023 |
Pignolo RJ, Hsiao EC, Mukaddam MA, Baujat G, Berglund SK, Brown MA, Cheung AM, Cunto CD, Delai P, Haga N, Kannu P, Keen R, Sang K-HLQ, Mancilla EE, Marino R, Strahs A, Kaplan FS. Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res. March 2023;38(3):381-394. |
0 |
0 |